Perforation intestinale : complication rare du traitement d’un cancer du sein métastatique par bevacizumab et paclitaxel-Reference-Cited by-同舟云学术

Perforation intestinale : complication rare du traitement d’un cancer du sein métastatique par bevacizumab et paclitaxel

Published:2009-09 Issue:9 Volume:38 Page:1370-1374
ISSN:0755-4982
Container-title:La Presse Médicale
language:fr
Short-container-title:La Presse Médicale

Author:

Mychaluk Johanna,Piprot Christine,Sevestre Henri,Merviel Philippe,Gondry Jean,Fauvet Raffaèle

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. La fréquence des cancers en France en 2005 : évolution de la mortalité depuis 1950 et résumé du rapport sur les causes de cancer;Hill;Bull Cancer,2008

2. Bevacizumab: in first-line treatment of metastatic breast cancer;Scott;Drugs,2007

3. Mechanisms of adverse effects of anti-VEGF therapy for cancer;Kamba;Br J Cancer,2007

4. Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events;Hurwitz;Semin Oncol,2006

5. Gastrointestinal perforation due to bevacizumab in colorectal cancer;Saif;Ann Surg Oncol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Unusual Case of Colon Perforation With Multiple Transmural Ulcers After Use of Polmacoxib and Everolimus in a Metastatic Breast Cancer Patient;Annals of Coloproctology;2021-04-30

2. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature;Journal of Medical Case Reports;2018-03-27

3. A Case of Intestinal Perforation during Bevacizumab Combination Chemotherapy for Inoperable Advanced Breast Cancer;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2016